MAV+ Project launched to boost Biotechnology & Biomanufacturing capacity in Rwanda

UR has launched the MAV+ Project, a flagship initiative designed to position Rwanda as a regional hub for biomanufacturing and translational health sciences, in alignment with the country’s Vision 2050.

A ribbon cutting to launch MAV+ Project

The launch event brought together representatives from the Ministry of Education, the Swedish Embassy in Rwanda, and the European Union, marking a key milestone in Rwanda’s growing investment in science, research, and innovation. The celebration also recognized the first cohort of MSc Biotechnology graduates, whose success reflects Rwanda’s commitment to building a strong foundation in biotechnology and human capital development.

Led by Professor Leon Mutesa, Director of the Centre for Human Genetics at UR, the MAV+ Project has already made major strides with the accreditation of two new academic programs ; a MSc in Clinical Trials and a PhD in Translational Health Sciences. These programs aim to equip Rwandan scientists and researchers with the advanced skills needed to drive innovation in biomedical and pharmaceutical industries.

Prof. Leon Mutesa, the leading figure of MAV+ Project

The project underscores Rwanda’s unwavering investment in research and development, with a focus on achieving health sovereignty and sustainable national growth. It represents a critical step toward establishing Rwanda as a centre of excellence in biopharmaceutical innovation.

The launch also served as a platform for academia, development partners, and stakeholders to exchange insights and strengthen collaboration in advancing biotechnology, biomanufacturing, and translational health sciences across Rwanda and the region.

Group photo of participants during the launch of MAV+ Project